Terms: = Lung cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC AND Clinical Outcome
5 results:
1. Genetic polymorphisms of GSTP1, XRCC1, xpc and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh.
Bushra MU; Rivu SF; Sifat AE; Nahid NA; Ahmed MU; Al-Mamun MMA; Apu MNH; Islam MS; Islam MR; Islam MS; Hasnat A
Mol Biol Rep; 2020 Sep; 47(9):7073-7082. PubMed ID: 32880833
[TBL] [Abstract] [Full Text] [Related]
2. Genetic variants in ERCC1 and xpc predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy.
Zhang R; Jia M; Xue H; Xu Y; Wang M; Zhu M; Sun M; Chang J; Wei Q
Sci Rep; 2017 Sep; 7(1):10702. PubMed ID: 28878296
[TBL] [Abstract] [Full Text] [Related]
3. Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis.
Dong J; Hu Z; Shu Y; Pan S; Chen W; Wang Y; Hu L; Jiang Y; Dai J; Ma H; Jin G; Shen H
Mol Carcinog; 2012 Jul; 51(7):546-52. PubMed ID: 21739480
[TBL] [Abstract] [Full Text] [Related]
4. Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer.
Campayo M; Viñolas N; Navarro A; Carcereny E; Casas F; Gel B; Diaz T; Gimferrer JM; Marrades RM; Ramirez J; Monzo M
J Surg Res; 2011 May; 167(1):e5-12. PubMed ID: 21324488
[TBL] [Abstract] [Full Text] [Related]
5. Reduced xpc messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract] [Full Text] [Related]
